134 related articles for article (PubMed ID: 29948421)
21. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
[TBL] [Abstract][Full Text] [Related]
22. Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.
Osako Y; Seki N; Kita Y; Yonemori K; Koshizuka K; Kurozumi A; Omoto I; Sasaki K; Uchikado Y; Kurahara H; Maemura K; Natsugoe S
Int J Oncol; 2016 Dec; 49(6):2255-2264. PubMed ID: 27779648
[TBL] [Abstract][Full Text] [Related]
23. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
Komatsu S; Ichikawa D; Takeshita H; Tsujiura M; Morimura R; Nagata H; Kosuga T; Iitaka D; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2011 Jun; 105(1):104-11. PubMed ID: 21673684
[TBL] [Abstract][Full Text] [Related]
27. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
28. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
29. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of microRNA-1 in esophageal squamous cell carcinoma correlates with an advanced clinical stage and its overexpression inhibits cell migration and invasion.
Yao L; Zhang Y; Zhu Q; Li X; Zhu S; Gong L; Han X; Lan M; Li S; Zhang W; Li Y
Int J Mol Med; 2015 Apr; 35(4):1033-41. PubMed ID: 25672418
[TBL] [Abstract][Full Text] [Related]
31. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
32. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
[TBL] [Abstract][Full Text] [Related]
34. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
35. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
36. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
38. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
[TBL] [Abstract][Full Text] [Related]
39. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
40. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.
Wei J; Zheng L; Liu S; Yin J; Wang L; Wang X; Shi Y; Shao A; Tang W; Ding G; Liu C; Chen S; Gu H
Hum Immunol; 2013 Sep; 74(9):1199-205. PubMed ID: 23792053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]